{"meta":{"query_hash":"37251a306fe1","filters":{"venue":"Molecular Therapy Oncology"},"cohort_total":15,"direct_labels_cover":0,"predictions_cover":15,"exported":15,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/37251a306fe1","api":"https://metacan.xera.ac/api/v1/cohort?venue=Molecular+Therapy+Oncology"},"results":[{"id":"W4391774222","doi":"10.1016/j.omton.2024.200775","title":"Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Ottawa Hospital; University of Ottawa; Terry Fox Research Institute; University of British Columbia; Concordia University; National Research Council Canada; Canada's Michael Smith Genome Sciences Centre; Institute of Infection and Immunity","funders":"BC Cancer Agency; National Research Council Canada; Ottawa Hospital Research Institute","keywords":"CD22; Epitope; Antigen; Antibody; Molecular biology; Biology; Immunology; B cell","score_opus":0.0504285465343114,"score_gpt":0.4044585089451424,"score_spread":0.354029962410831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391774222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95030874,0.004766431,0.03425663,0.00056230807,0.00013735093,0.0014039755,0.0013041453,0.00041997334,0.006840437],"genre_scores_gemma":[0.97854596,0.002888897,0.011139262,0.00019912515,0.00003525383,0.0006473961,0.0015046052,0.000037628848,0.0050017377],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986875,0.000019762396,0.000008297755,0.00002267097,0.00003950175,0.000041015897],"domain_scores_gemma":[0.9999099,0.0000064547908,0.000015604284,0.000012459876,0.000017037568,0.000038538998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039518828,0.00046396643,0.00031147434,0.00029511633,0.00015430305,0.00048552037,0.00036027085,0.0004499742,0.0012785059],"category_scores_gemma":[0.00013191625,0.00018875768,0.00039471197,0.00012512902,0.00020520088,0.00028916638,0.00019972779,0.0008391472,0.0005582809],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026457675,0.00072969816,0.00016693937,0.00010456597,0.000016202359,0.00010340866,0.000032330896,0.0010460597,0.9892162,0.00048986654,0.00035826451,0.0074718096],"study_design_scores_gemma":[0.00017725401,0.00992716,0.00094103086,0.000019343652,0.00005533665,0.000389425,0.00002081193,0.0022130862,0.9739248,0.00013935627,0.012183659,0.000008707549],"about_ca_topic_score_codex":0.00038382434,"about_ca_topic_score_gemma":0.0005308864,"teacher_disagreement_score":0.0012785059,"about_ca_system_score_codex":0.00038049088,"about_ca_system_score_gemma":0.00041793045,"threshold_uncertainty_score":0.0042770505},"labels":[],"label_agreement":null},{"id":"W4392056118","doi":"10.1016/j.omton.2024.200780","title":"Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotype","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; Fondation ARC pour la Recherche sur le Cancer","keywords":"Oncolytic virus; Phenotype; Pancreatic cancer; Mesenchymal stem cell; Virus; Cancer research; Cancer; Virology; Biology; Medicine; Pathology; Internal medicine; Gene; Genetics","score_opus":0.02447461293057466,"score_gpt":0.33061703419487093,"score_spread":0.30614242126429625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392056118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865545,0.0018672326,0.006999165,0.00031663026,0.000077284,0.00009518667,0.0009013516,0.0002713401,0.0029172213],"genre_scores_gemma":[0.98619384,0.00150111,0.0055024954,0.000079334,0.000026513997,0.00011552203,0.001365653,0.000058720187,0.00515678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99974805,0.000052625714,0.00002397167,0.00005616512,0.000052478266,0.00006673375],"domain_scores_gemma":[0.99980587,0.000033312317,0.000072436145,0.000026186392,0.000007893791,0.000054349264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021094883,0.0005993913,0.00029737243,0.00047537216,0.00018667466,0.0003888595,0.00026085685,0.0005925586,0.0016512249],"category_scores_gemma":[0.00012728907,0.0002398126,0.0003583543,0.00019095605,0.0003745322,0.00032319422,0.00024093811,0.0011584442,0.00036099934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017363178,0.000056066157,0.00017113611,0.000027156435,0.000007785578,0.00003668104,0.000017434968,0.000057493246,0.99779236,0.00041212916,0.00006101766,0.0011872076],"study_design_scores_gemma":[0.000051794832,0.0016408869,0.0021306383,0.000014325492,0.000025727499,0.00056507677,0.000028706136,0.00084774854,0.9894693,0.00014112417,0.0050780484,0.000006628663],"about_ca_topic_score_codex":0.0003698492,"about_ca_topic_score_gemma":0.00050083426,"teacher_disagreement_score":0.0016512249,"about_ca_system_score_codex":0.00023376466,"about_ca_system_score_gemma":0.00023442933,"threshold_uncertainty_score":0.00552392},"labels":[],"label_agreement":null},{"id":"W4392179420","doi":"10.1016/j.omton.2024.200774","title":"The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Cancer therapy; Viral therapy; Cancer; Cancer treatment; Medical physics; Coronavirus disease 2019 (COVID-19); Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.044528206211064826,"score_gpt":0.4411964929011777,"score_spread":0.39666828669011284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392179420","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011122471,0.26412833,0.007953865,0.35484254,0.27302817,0.00025755854,0.0009285013,0.0009036255,0.08683505],"genre_scores_gemma":[0.10198477,0.16053468,0.009445431,0.12734248,0.070480496,0.00031394634,0.0025565815,0.00077018415,0.52657145],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835,0.00027279535,0.000056523946,0.00014307113,0.000747129,0.00043041012],"domain_scores_gemma":[0.99818367,0.00018866097,0.00008222305,0.000056142413,0.0005918756,0.00089744467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005133848,0.00093280885,0.00068091444,0.0007053767,0.0013396032,0.006037862,0.00079608674,0.004698747,0.02023873],"category_scores_gemma":[0.003009947,0.00024054835,0.0008353359,0.0004980281,0.001606274,0.0022632752,0.0024437585,0.006470196,0.0069651445],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036099192,0.00012299269,0.00046984307,0.00033111495,0.00003549446,0.00014868626,0.00012256378,0.00022403407,0.002883146,0.0063880435,0.84995735,0.13895576],"study_design_scores_gemma":[0.000037886468,0.00015047312,0.00062779523,0.00014888211,0.000017367922,0.00014296036,0.0001098829,0.00010571468,0.0015657813,0.001503466,0.99557084,0.000018913875],"about_ca_topic_score_codex":0.0034808894,"about_ca_topic_score_gemma":0.008974306,"teacher_disagreement_score":0.02023873,"about_ca_system_score_codex":0.003745079,"about_ca_system_score_gemma":0.0052646813,"threshold_uncertainty_score":0.06770527},"labels":[],"label_agreement":null},{"id":"W4392247444","doi":"10.1016/j.omton.2024.200783","title":"Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; Children's Cancer Research Fund; National Institutes of Health; American Cancer Society","keywords":"Oncolytic virus; Cancer research; Neurofibromatosis; Oncolytic adenovirus; CD8; Malignant peripheral nerve sheath tumor; In vivo; Immunotherapy; Biology; Medicine; Immunology; Pathology; Immune system; Tumor cells","score_opus":0.0252161962129652,"score_gpt":0.3544983500566761,"score_spread":0.3292821538437109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392247444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685006,0.007513387,0.020088425,0.00015850077,0.00010968269,0.00012911164,0.000310175,0.00028768939,0.002902462],"genre_scores_gemma":[0.9844525,0.0033913164,0.008823001,0.000029947174,0.000013209199,0.000054763976,0.0002867638,0.000023788578,0.002924713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999882,0.000025722495,0.0000081622875,0.000024748526,0.00003865501,0.000020792148],"domain_scores_gemma":[0.99994624,0.000012083359,0.000015645755,0.000010951609,0.0000059747067,0.000009152332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021061902,0.00037365223,0.00016707058,0.00019873523,0.00007662402,0.00030805188,0.00022727641,0.0002591412,0.0006539595],"category_scores_gemma":[0.00012688723,0.00007551051,0.00014385518,0.00010427497,0.00029034403,0.00025073718,0.00015966297,0.00037737607,0.00018437572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007815799,0.00004169508,0.000116852345,0.000054407967,0.000004098163,0.00004359484,0.000014980296,0.00024677272,0.9955291,0.0005815093,0.000047480782,0.0032411783],"study_design_scores_gemma":[0.000019876294,0.00087293156,0.0006562493,0.000009297689,0.00002039003,0.0003680758,0.000013888743,0.0012427921,0.99041057,0.00008273121,0.0062975064,0.0000057147495],"about_ca_topic_score_codex":0.00053028,"about_ca_topic_score_gemma":0.0005563494,"teacher_disagreement_score":0.0006539595,"about_ca_system_score_codex":0.00032859773,"about_ca_system_score_gemma":0.00029926776,"threshold_uncertainty_score":0.0023841858},"labels":[],"label_agreement":null},{"id":"W4399616908","doi":"10.1016/j.omton.2024.200825","title":"Transforming pancreaticobiliary cancer treatment: Exploring the frontiers of adoptive cell therapy and cancer vaccines","year":2024,"lang":"en","type":"review","venue":"Molecular Therapy Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Immunotherapy; Pancreatic cancer; Cancer; Modalities; Cancer immunotherapy; Asymptomatic; Intensive care medicine; Internal medicine","score_opus":0.13224394947622756,"score_gpt":0.41514079543486426,"score_spread":0.28289684595863673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399616908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001321529,0.9983192,0.0001359682,0.00048407336,0.00020856898,0.0000042117185,0.000009942433,0.0000057923676,0.0007000699],"genre_scores_gemma":[0.0006950018,0.9984919,0.0001319698,0.00023216069,0.00012132901,0.0000053358244,0.000016151902,9.64035e-7,0.00030516044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981886,0.00004417399,0.00001855903,0.000024348989,0.00006809645,0.000025962632],"domain_scores_gemma":[0.9997353,0.00013878095,0.00003040796,0.000008840322,0.00006366999,0.00002307248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006377085,0.0005377726,0.0009898499,0.0014232654,0.00020644315,0.0010492431,0.00060449936,0.00094796624,0.0028668423],"category_scores_gemma":[0.00067144615,0.00017170313,0.00053823617,0.0011127134,0.00045158798,0.001215164,0.00061933993,0.001902417,0.0010886338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064554,0.00008123353,0.0001314723,0.015719809,0.00007963505,0.00016010596,0.00006664592,0.00044934824,0.002462143,0.0068752314,0.024578348,0.94933146],"study_design_scores_gemma":[0.000025384103,0.00012810068,0.00049319316,0.0046835365,0.000089213514,0.00081813964,0.00006869334,0.00012570196,0.0006646305,0.003361565,0.9895287,0.000013116544],"about_ca_topic_score_codex":0.0006147965,"about_ca_topic_score_gemma":0.0012577813,"teacher_disagreement_score":0.0028668423,"about_ca_system_score_codex":0.00062088604,"about_ca_system_score_gemma":0.0011553383,"threshold_uncertainty_score":0.009590507},"labels":[],"label_agreement":null},{"id":"W4399654129","doi":"10.1016/j.omton.2024.200826","title":"Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institute of Cancer Research; Institut Du Cancer de Montréal; Université de Montréal; Ovarian Cancer Canada; Fondation du cancer du sein du Québec","keywords":"Oncolytic virus; Vesicular stomatitis virus; Ovarian cancer; Ruxolitinib; Virotherapy; Medicine; Cancer research; Virology; Oncology; Virus; Cancer; Immunology; Internal medicine; Myelofibrosis; Bone marrow","score_opus":0.011429317458301487,"score_gpt":0.3174423639702004,"score_spread":0.3060130465118989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399654129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855376,0.008973855,0.0005972109,0.00015006887,0.000070360016,0.000042652722,0.00017522255,0.00003114629,0.001405731],"genre_scores_gemma":[0.99562377,0.0027956527,0.0005916614,0.000038118695,0.000016524336,0.000016848386,0.00022355668,0.000006736941,0.0006871044],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998809,0.00003321625,0.000011366664,0.000015645584,0.000031364558,0.00002756735],"domain_scores_gemma":[0.99994063,0.000017362476,0.0000115891335,0.000008653478,0.0000061569326,0.000015581265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001818731,0.00017837997,0.00046275507,0.0002637649,0.00012447768,0.0003958121,0.00013851271,0.00017159608,0.0008426275],"category_scores_gemma":[0.00012454644,0.00007467612,0.0002346015,0.00020696248,0.00015491573,0.00019287338,0.0001368778,0.0004408138,0.00011511368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016056997,0.0005824126,0.0024568588,0.00029428425,0.00012992662,0.000097001255,0.00005946284,0.0012082389,0.95267993,0.00032526848,0.00047164693,0.04008924],"study_design_scores_gemma":[0.00036358164,0.013147193,0.02197424,0.00004668487,0.00029121392,0.00086330256,0.0001258943,0.0036755884,0.94113064,0.00018913145,0.018173832,0.000018595052],"about_ca_topic_score_codex":0.0003965565,"about_ca_topic_score_gemma":0.0015748191,"teacher_disagreement_score":0.0008426275,"about_ca_system_score_codex":0.00019767332,"about_ca_system_score_gemma":0.00021677169,"threshold_uncertainty_score":0.0028188825},"labels":[],"label_agreement":null},{"id":"W4399961712","doi":"10.1016/j.omton.2024.200842","title":"Electrophilic proximity-inducing synthetic adapters enhance universal T cell function by covalently enforcing immune receptor signaling","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Discovery Centre","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Signalling; Electrophile; Covalent bond; Chemistry; Function (biology); Immune system; Combinatorial chemistry; Receptor; Cell biology; Stereochemistry; Biochemistry; Biology; Immunology; Organic chemistry","score_opus":0.006259187279070489,"score_gpt":0.24678632822464225,"score_spread":0.24052714094557176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399961712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993087,0.0010615404,0.007217476,0.000047766764,0.000019080548,0.00005226981,0.00007266688,0.00006684033,0.0015314518],"genre_scores_gemma":[0.9945781,0.00047746158,0.004044849,0.00003429684,0.00000804862,0.000029856208,0.00006395973,0.0000073447245,0.00075603457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998511,0.00003430543,0.000014718099,0.000031270978,0.000030655556,0.000037994098],"domain_scores_gemma":[0.99987614,0.000023548075,0.000051433384,0.000015223469,0.000011866682,0.000021665366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019767124,0.000334816,0.00014076896,0.0001384933,0.00007321015,0.00023525624,0.00015345553,0.00025510177,0.0012155853],"category_scores_gemma":[0.00022588838,0.00009258237,0.0001476818,0.00013425873,0.00017180301,0.0002639752,0.00028792568,0.0004676957,0.00023915271],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065795386,0.000021994452,0.00008970678,0.000043826458,0.0000038603143,0.00002270835,0.000010166034,0.00013517575,0.9974929,0.00022988181,0.000019311054,0.0018648017],"study_design_scores_gemma":[0.000010929443,0.00042993252,0.0004207539,0.0000029225887,0.000008803791,0.000073210074,0.000009176329,0.0005623333,0.99725276,0.00003011719,0.001196331,0.0000027196666],"about_ca_topic_score_codex":0.00008879469,"about_ca_topic_score_gemma":0.0002118084,"teacher_disagreement_score":0.0012155853,"about_ca_system_score_codex":0.00014641648,"about_ca_system_score_gemma":0.000117160074,"threshold_uncertainty_score":0.004066527},"labels":[],"label_agreement":null},{"id":"W4400142684","doi":"10.1016/j.omton.2024.200846","title":"The reovirus variant RP116 is oncolytic in immunocompetent models and generates reduced neutralizing antibodies to Type 3 Dearing","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Korea Health Industry Development Institute; Terry Fox Research Institute; Canadian Cancer Society; Ministry of Health and Welfare; National Institute of Environmental Health Sciences; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ministry of SMEs and Startups; Cancer Research Society","keywords":"Oncolytic virus; Biology; Antibody; Virology; Mutation; Virus; Cancer research; Cancer cell; Cell culture; Cancer; Gene; Molecular biology; Immunology; Genetics","score_opus":0.04077364010863711,"score_gpt":0.3526124107906218,"score_spread":0.3118387706819847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400142684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99155563,0.0009987445,0.0046747797,0.00014465871,0.00007021967,0.000056351673,0.00051864283,0.00021211179,0.0017689128],"genre_scores_gemma":[0.9915433,0.0006753716,0.003026038,0.000063159416,0.000016602837,0.000048457317,0.0009468456,0.00006504484,0.003615304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997719,0.000034518842,0.00001937669,0.000054410895,0.00006829922,0.00005150616],"domain_scores_gemma":[0.99975413,0.00003978924,0.00009417345,0.0000332976,0.000016065333,0.000062520834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021949729,0.000715214,0.00030631345,0.00043985844,0.00014204273,0.0004440708,0.0003152986,0.00054827565,0.0013541412],"category_scores_gemma":[0.000198437,0.00016156213,0.00029205033,0.00014159203,0.00036406785,0.0003819413,0.00017698426,0.0013804,0.00038314326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116408286,0.000043455555,0.00006372312,0.000015522452,0.00000427236,0.000036713216,0.000008210111,0.00007185556,0.998862,0.00008912693,0.000029544608,0.0006591224],"study_design_scores_gemma":[0.000023176199,0.0007272546,0.0008658806,0.000005551392,0.000011319526,0.00038681668,0.000009002183,0.00051537575,0.99620074,0.0000332303,0.0012169672,0.000004676814],"about_ca_topic_score_codex":0.00046988373,"about_ca_topic_score_gemma":0.00040374664,"teacher_disagreement_score":0.0013541412,"about_ca_system_score_codex":0.00026510036,"about_ca_system_score_gemma":0.00016911686,"threshold_uncertainty_score":0.0045300126},"labels":[],"label_agreement":null},{"id":"W4401219445","doi":"10.1016/j.omton.2024.200851","title":"Minimally modified off-the-shelf allogeneic CAR T cells","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Canada's Michael Smith Genome Sciences Centre","funders":"BC Cancer Foundation; Canadian Institutes of Health Research; Fonds Léon Fredericq; Terry Fox Research Institute; Michael Smith Health Research BC","keywords":"Chimeric antigen receptor; Cell therapy; Medicine; Cancer research; In vivo; Induced pluripotent stem cell; Immunotherapy; Stem cell; Immunology; Chemistry; Biology; Biotechnology; Immune system; Cell biology","score_opus":0.03441878770243568,"score_gpt":0.343309674273072,"score_spread":0.30889088657063635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401219445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70297104,0.09933576,0.11142134,0.001928047,0.0018916137,0.0020442125,0.009316733,0.0027693177,0.068321936],"genre_scores_gemma":[0.8410843,0.036765277,0.05264643,0.0019337225,0.00025122685,0.0011632344,0.013288735,0.00030093535,0.052566208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99979264,0.000025646495,0.000011230675,0.00003895675,0.00010662311,0.000024904892],"domain_scores_gemma":[0.9999238,0.000010975642,0.000018040426,0.000011503184,0.000022150016,0.000013554064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020732112,0.00032358698,0.00025893844,0.00032764487,0.00008456981,0.00049085176,0.00043953402,0.00045345776,0.0042331587],"category_scores_gemma":[0.0002169669,0.00011639296,0.00033421582,0.00022575424,0.00012510372,0.00031650328,0.0003059437,0.0006441416,0.0028862213],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005313289,0.0002488106,0.00038335627,0.00072087726,0.00003134978,0.0002731688,0.00004648892,0.00043016407,0.88479495,0.0011204482,0.0048781224,0.10654109],"study_design_scores_gemma":[0.00013460328,0.0027230172,0.0021267335,0.00009990302,0.00013467674,0.0020525097,0.000058243695,0.0012735327,0.7992022,0.00059077935,0.19157429,0.000029497385],"about_ca_topic_score_codex":0.00030211874,"about_ca_topic_score_gemma":0.0005340951,"teacher_disagreement_score":0.0042331587,"about_ca_system_score_codex":0.00020286719,"about_ca_system_score_gemma":0.0003062101,"threshold_uncertainty_score":0.014161289},"labels":[],"label_agreement":null},{"id":"W4402784527","doi":"10.1016/j.omton.2024.200876","title":"Innovative approaches to glioma treatment: Oncolytic foamy virus and CAR T cell therapy","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Oncolytic virus; Glioma; Virology; Virus; Medicine; Cancer research","score_opus":0.12167697695646601,"score_gpt":0.35955457143196046,"score_spread":0.23787759447549445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402784527","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17455326,0.652439,0.10533797,0.030766116,0.0036854714,0.0005082849,0.000332902,0.0005284687,0.03184851],"genre_scores_gemma":[0.7135362,0.23082256,0.03448646,0.004734847,0.0029541182,0.0004052868,0.00029155932,0.00006186062,0.012707069],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99980193,0.000052053965,0.0000063300085,0.00003548885,0.000044762066,0.000059385846],"domain_scores_gemma":[0.9998901,0.00003752742,0.000019257313,0.000009851745,0.000020594536,0.000022591985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062571926,0.0005800348,0.00051110785,0.00087939674,0.00029465946,0.0013339956,0.00065497373,0.001219781,0.0021192017],"category_scores_gemma":[0.00034565863,0.00014158365,0.0005722397,0.0004832731,0.0011130802,0.0014751168,0.00069460063,0.0018455322,0.00042323288],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017150227,0.0012068298,0.0012967449,0.0017616877,0.0002274209,0.0010777159,0.000357608,0.0038103187,0.17401944,0.10231978,0.015739882,0.69646746],"study_design_scores_gemma":[0.0020473814,0.012679285,0.0055558197,0.001050528,0.00051711046,0.0077143232,0.000943136,0.019176824,0.26609823,0.11983624,0.5641477,0.00023340045],"about_ca_topic_score_codex":0.001360761,"about_ca_topic_score_gemma":0.001518801,"teacher_disagreement_score":0.0021192017,"about_ca_system_score_codex":0.00089179905,"about_ca_system_score_gemma":0.00095386116,"threshold_uncertainty_score":0.0070894957},"labels":[],"label_agreement":null},{"id":"W4404459656","doi":"10.1016/j.omton.2024.200906","title":"Virus replication is not required for oncolytic bovine herpesvirus-1 immunotherapy","year":2024,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Natural Sciences and Engineering Research Council of Canada; Terry Fox Research Institute; Canadian Cancer Society; Canadian Cancer Society Research Institute; Cancer Research Society","keywords":"Oncolytic virus; Virology; Replication (statistics); Virus; Biology; Immunotherapy; Bovine herpesvirus 1; Medicine; Immunology; Herpesviridae; Immune system; Viral disease","score_opus":0.04081639528462821,"score_gpt":0.37479844865649625,"score_spread":0.33398205337186804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404459656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575497,0.0059745396,0.0052998257,0.00020068396,0.00008760463,0.00005095033,0.0007273212,0.00012827321,0.0017758559],"genre_scores_gemma":[0.99503785,0.00076487823,0.0017630848,0.000062827734,0.000011077905,0.000041879448,0.00092543656,0.00002229123,0.0013708007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9996418,0.000058761918,0.000022251754,0.00007292097,0.00011839629,0.00008577356],"domain_scores_gemma":[0.9997378,0.00008284496,0.00007798374,0.000035436926,0.000029610443,0.0000364256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017543383,0.00017688608,0.0003326474,0.00016456663,0.00018129377,0.00054564344,0.00015520923,0.000297582,0.001268063],"category_scores_gemma":[0.00038979758,0.00010841099,0.00021026086,0.0001231118,0.0002669613,0.00039534256,0.0001809349,0.00065358565,0.00033662934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079520316,0.000026261332,0.0005718884,0.000046787096,0.0000046110226,0.000023016692,0.000014825856,0.000081689795,0.9972524,0.00014850189,0.00006074984,0.0016897075],"study_design_scores_gemma":[0.000018643545,0.0006734188,0.017600609,0.000020839161,0.000028636909,0.0004964224,0.00008800774,0.0022015956,0.9691329,0.00033633295,0.009392476,0.000010209246],"about_ca_topic_score_codex":0.0005152868,"about_ca_topic_score_gemma":0.00062391046,"teacher_disagreement_score":0.001268063,"about_ca_system_score_codex":0.00041397108,"about_ca_system_score_gemma":0.00035287804,"threshold_uncertainty_score":0.0042420626},"labels":[],"label_agreement":null},{"id":"W4408856819","doi":"10.1016/j.omton.2025.200977","title":"Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Miltenyi Biotec; Indian Council of Medical Research","keywords":"CAR T-cell therapy; CD19; Cell therapy; Medicine; Internal medicine; Cell; Chimeric antigen receptor; Immunotherapy; Chemistry","score_opus":0.015318148437875842,"score_gpt":0.3357818229476246,"score_spread":0.3204636745097488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408856819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485636,0.0006845744,0.00037825268,0.0002486385,0.000045549223,0.0009857778,0.00076355966,0.00007307638,0.0019641737],"genre_scores_gemma":[0.9940446,0.00045168735,0.0006256975,0.00034986457,0.000076505865,0.0010536414,0.0013507836,0.00001895138,0.002028223],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996253,0.00018477747,0.0000122323645,0.000037055222,0.00003543078,0.00010517996],"domain_scores_gemma":[0.99956805,0.000093914765,0.00009122989,0.00005640265,0.000019628053,0.00017072733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009957578,0.00086532236,0.0009449179,0.00043006157,0.00031593922,0.0011196149,0.00084486295,0.0010917785,0.004623745],"category_scores_gemma":[0.0006739037,0.0004110078,0.0009657945,0.0005288384,0.00089822855,0.0006385713,0.00037131942,0.0022411826,0.0009704563],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.812502,0.043359466,0.012307788,0.00052643166,0.00084550463,0.00047966308,0.0002024761,0.0035462133,0.014219913,0.0006471041,0.0031465234,0.10821698],"study_design_scores_gemma":[0.4985039,0.4604427,0.027271306,0.000058479312,0.00074514205,0.0005733644,0.000119128286,0.0021443325,0.005040079,0.0005184685,0.0045276126,0.000055532357],"about_ca_topic_score_codex":0.00075622887,"about_ca_topic_score_gemma":0.0010712679,"teacher_disagreement_score":0.004623745,"about_ca_system_score_codex":0.0009355882,"about_ca_system_score_gemma":0.0011192141,"threshold_uncertainty_score":0.015467942},"labels":[],"label_agreement":null},{"id":"W4411632146","doi":"10.1016/j.omton.2025.201016","title":"Intravesical VSVd51-GM-CSF virotherapy is superior to BCG in treating bladder cancer in preclinical and translational models","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Virotherapy; Bladder cancer; Medicine; Cancer research; Cancer; Urology; Oncology; Oncolytic virus; Internal medicine","score_opus":0.03738937015852793,"score_gpt":0.3985951182135021,"score_spread":0.36120574805497413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411632146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948002,0.0031019372,0.0008185156,0.00011109062,0.0000491214,0.000057581357,0.00018817377,0.00006613179,0.00080724905],"genre_scores_gemma":[0.9966311,0.001282277,0.0007154771,0.000046628007,0.000018220095,0.00005980364,0.00030460078,0.000012142596,0.0009297846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998671,0.000032645705,0.000011760806,0.000023424293,0.000026892785,0.000038065496],"domain_scores_gemma":[0.9998642,0.000018809871,0.00003713424,0.00002020716,0.000011373024,0.000048238573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028885886,0.0003157811,0.0005083294,0.00026518604,0.000119216114,0.00037839919,0.00024744865,0.00047167297,0.0006020987],"category_scores_gemma":[0.00015708327,0.00012424822,0.000277667,0.00020126595,0.00035448567,0.00031500444,0.00014322791,0.00078439387,0.00014460678],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034700073,0.0010520304,0.00037173252,0.00019038803,0.000029565494,0.00002768781,0.000042998017,0.00039911113,0.98249304,0.00018351532,0.00014443032,0.011595578],"study_design_scores_gemma":[0.0005277683,0.03128366,0.007939331,0.000034454417,0.00012955084,0.00022592195,0.000053853466,0.0017650843,0.9543941,0.00013204354,0.0034994127,0.000014737708],"about_ca_topic_score_codex":0.0005951835,"about_ca_topic_score_gemma":0.0009806607,"teacher_disagreement_score":0.0006020987,"about_ca_system_score_codex":0.0002927411,"about_ca_system_score_gemma":0.0004495751,"threshold_uncertainty_score":0.0021240711},"labels":[],"label_agreement":null},{"id":"W4413053270","doi":"10.1016/j.omton.2025.201028","title":"CHEK1 is a synthetic lethal interactor of FBXO7 in colonic epithelial cells","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Institute in Oncology and Hematology; CancerCare Manitoba","funders":"Canadian Institutes of Health Research; Max Rady College of Medicine, University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation","keywords":"Interactor; Computational biology; Biology; Cell biology","score_opus":0.011344057034844124,"score_gpt":0.32378221733785245,"score_spread":0.3124381603030083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413053270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782542,0.004148516,0.0056705517,0.0011476616,0.0002516461,0.000055024164,0.0040051,0.00034205627,0.0061252704],"genre_scores_gemma":[0.98755544,0.0011859646,0.0025733802,0.00019829231,0.000011369362,0.000044615794,0.0022159207,0.000052618303,0.006162381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99975806,0.000035993617,0.00002183271,0.000042467705,0.0000914428,0.000050303497],"domain_scores_gemma":[0.99987245,0.0000275642,0.000027952225,0.00001819009,0.0000109095645,0.00004283288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019967754,0.00039940284,0.00030704323,0.00036374625,0.0002855054,0.0004414789,0.00029294688,0.0006997295,0.004269726],"category_scores_gemma":[0.00017622903,0.00015037874,0.00040758302,0.00020915252,0.0003545168,0.00024217373,0.00029833594,0.0011828031,0.0009351617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030379932,0.00004534194,0.00052292657,0.00010424018,0.000028666735,0.00031646003,0.000012216358,0.00028921824,0.9940515,0.0004460296,0.0006676514,0.0032118452],"study_design_scores_gemma":[0.000052128576,0.00023972834,0.0065667247,0.000022667873,0.000033366363,0.0013547773,0.000078249555,0.002876762,0.9769358,0.00013448413,0.01169055,0.000014649792],"about_ca_topic_score_codex":0.0020430875,"about_ca_topic_score_gemma":0.0031647226,"teacher_disagreement_score":0.004269726,"about_ca_system_score_codex":0.0005466616,"about_ca_system_score_gemma":0.00039086462,"threshold_uncertainty_score":0.014283657},"labels":[],"label_agreement":null},{"id":"W4415760472","doi":"10.1016/j.omton.2025.201076","title":"Oncolytic Newcastle-disease-virus-mediated CD47 blockade in preclinical melanoma and pancreatic cancer models","year":2025,"lang":"en","type":"article","venue":"Molecular Therapy Oncology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Veterinary College, University of Guelph; Cancer Research Society","keywords":"Blockade; CD47; Oncolytic virus; Pancreatic cancer; Melanoma; Immune checkpoint; Immunotherapy; Cancer","score_opus":0.03774478426562772,"score_gpt":0.33928873361551815,"score_spread":0.30154394934989043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415760472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98340285,0.0018530751,0.007901998,0.0005397412,0.00024709917,0.00020970755,0.0009207942,0.0003085554,0.0046161762],"genre_scores_gemma":[0.9898996,0.0010967574,0.0029055567,0.00009061539,0.000024105948,0.00014642494,0.0005135597,0.000062374915,0.0052611358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997209,0.000057979032,0.000020423951,0.00004984605,0.00006249354,0.000088491484],"domain_scores_gemma":[0.99977773,0.000037164507,0.000054012395,0.000036116147,0.000022935814,0.000072110095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000430363,0.00049249467,0.0006081594,0.0003263698,0.0001870087,0.00058973103,0.00032116944,0.00040609567,0.0016310246],"category_scores_gemma":[0.00020833034,0.0001800783,0.00035212174,0.00016741201,0.0003856055,0.00047148505,0.00022118176,0.0018904652,0.000372567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011263653,0.001109633,0.00042402718,0.00018090256,0.000037896025,0.000060059603,0.00008647007,0.0008564249,0.98956805,0.00058819924,0.0006290823,0.005332986],"study_design_scores_gemma":[0.00009030986,0.0036526942,0.0011993251,0.000016388543,0.00004206421,0.00012019935,0.0000614191,0.0027663866,0.98887455,0.00014551559,0.0030246342,0.0000065019876],"about_ca_topic_score_codex":0.0016911662,"about_ca_topic_score_gemma":0.002972359,"teacher_disagreement_score":0.0016911662,"about_ca_system_score_codex":0.0005802905,"about_ca_system_score_gemma":0.0006669257,"threshold_uncertainty_score":0.0054563284},"labels":[],"label_agreement":null}]}